Pegylated interferon alfa-2B for chronic delta hepatitis: 12 versus 24 months

Hepato-Gastroenterology

Volumn 58, Issue 110-111, 2011, Pages 1648-1653

  Örmeci, Necati ^a   Bölükbaş, Füsun ^b   Erden, Esra ^a   Çoban, Şahin ^a   Ekiz, Fuat ^a   Erdem, Hakan ^c   Palabiyikoǧlu, Murat ^a   Beyler, Ali Reşit ^a   Balik, Ismail ^a   Bölükbaş, Cengiz ^b   Nazligül, Yaşar ^b   Köklü, Seyfettin ^d  

^a ANKARA UNIVERSITY   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

^c GULHANE SCHOOL OF MEDICINE   (Turkey)

^d ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

HDV; Pegylated interferon alfa 2b; Therapy

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; PEGINTERFERON ALPHA2B; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DELTA AGENT HEPATITIS; DEPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HEPATITIS DELTA VIRUS; HUMAN; LEUKOPENIA; LONG TERM CARE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; THROMBOCYTOPENIA;

ADULT; ANTIVIRAL AGENTS; FEMALE; HEPATITIS D, CHRONIC; HUMANS; INTERFERON-ALPHA; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 83355163497     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Rosina F, Rizzetto M: Treatment of chronic type D (delta) hepatitis with alpha interferon. Semin Liver Dis 1989; 9(4):264-6. (Pubitemid 20046476)
2. Ormeci N: Short- and long-term effects of treatment of chronic hepatitis B and delta virus by IFN. Fundam Clin Pharmacol 2003; 17(6):651-8.
3. Rosina F, Pintus C, Meschievitz C, Rizzetto M: A randomized controlled trial of a 12-month course of recombinant human interferon-alpha in chronic delta (type D) hepatitis: a multicenter Italian study. Hepatology 1991; 13(6):1052-6.
4. Hadziyannis SJ: Use of alpha-interferon in the treatment of chronic delta hepatitis. J Hepatol 1991; 13 Suppl 1:S21-6.
5. Deny P, Fattovich G, Le Gal F: Polymerase-chain-reaction-based semi-quantification of hepatitis D viraemia in patients treated with high doses of alpha 2b interferon. Res Virol 1994; 145:287-95. (Pubitemid 24316063)
6. Hadziyannis SJ: Review: hepatitis delta. J Gastroenterol Hepatol 1997; 12(4):289-98.
7. Niro GA, Ciancio A, Tillman HL, Lagget M, Olivero A, Perri F, et al.: Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study. Aliment Pharmacol Ther 2005; 22(3):227-32. (Pubitemid 41153065)
8. Gunsar F, Akarca US, Ersoz G, Kobak AC, Karasu Z, Yuce G, et al.: Two-year interferon therapy with or without ribavirin in chronic delta hepatitis. Antivir Ther 2005; 10(6):721-6. (Pubitemid 41376851)
9. Kaymakoglu S, Karaca C, Demir K, Poturoglu S, Danalioglu A, Badur S, et al.: Alpha interferon and ribavirin combination therapy of chronic hepatitis D. Antimicrob Agents Chemother 2005; 49(3):1135-8. (Pubitemid 40327735)
10. Canbakan B, Senturk H, Tabak F, Akdogan M, Tahan V, Mert A, et al.: Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: a randomized trial. J Gastroenterol Hepatol 2006; 21(4):657-63.
11. Rosa I, Costes L, Garrait V, Chousterman M: Efficacy of pegylated interferon alpha-2b for the treatment of chronic delta hepatitis in a patient co-infected with HIV. AIDS 2005; 19:2177-85.
12. Ferenci P, Formann E, Romeo R: Successful treatment of chronic hepatitis D with a short course of peginterferon alfa-2a. Am J Gastroenterol 2005; 100(7): 1626-27. (Pubitemid 41032380)
13. Niro GA, Ciancio A, Gaeta GB, Smedile A, Marrone A, Olivero A, et al.: Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta. Hepatology 2006; 44(3):713-20. (Pubitemid 44433728)
14. Castelnau C, Le Gal F, Ripault MP, Gordien E, Martinot-Peignoux M, Boyer N, et al.: Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology 2006; 44(3):728-35. (Pubitemid 44433730)
15. Takahashi M, Nishizawa T, Gotanda Y, Tsuda F, Komatsu F, Kawabata T, et al.: High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C, and D viruses among apparently healthy populations in Mongolia. Clin Diagn Lab Immunol 2004; 11(2):392-8. (Pubitemid 38380823)
16. Lau JY, King R, Tibbs CJ, Catterall AP, Smith HM, Portmann BC, et al.: Loss of HBsAg with interferon-alpha therapy in chronic hepatitis D virus infection. J Med Virol 1993; 39(4):292-6. (Pubitemid 23128423)
17. Carreno V, Bartolome J, Madejon A: Hepatitis delta virus infection: molecular biology and treatment. Dig Dis 1994; 12(5):265-75.
18. Puoti M, Rossi S, Forleo MA, Zaltron S, Spinetti A, Putzolu V, et al.: Treatment of chronic hepatitis D with interferon alpha-2b in patients with human immunodeficiency virus infection. J Hepatol 1998; 29(1):45-52. (Pubitemid 28307982)
19. Madejon A, Cotonat T, Bartolome J, Castillo I, Carreno V: Treatment of chronic hepatitis D virus infection with low and high doses of interferon-alpha 2a: utility of polymerase chain reaction in monitoring antiviral response. Hepatology 1994; 19(6):1331-6.
20. Farci P, Mandas A, Coiana A, Lai ME, Desmet V, Van Eyken P, et al.: Treatment of chronic hepatitis D with interferon alfa-2a. N Engl J Med 1994; 330(2):88-94.
21. Gaudin JL, Faure P, Godinot H, Gerard F, Trepo C: The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trial. Liver 1995; 15(1):45-52.
22. Rosina F, Cozzolongo R: Interferon in HDV infection. Antiviral Res 1994; 24(2-3):165-74. (Pubitemid 24228872)
23. Colombo P, Di Blasi F, Magrin S, Fabiano C, Di Marco V, D'Amelio L, et al.: Smouldering hepatitis B virus replication in patients with chronic liver disease and hepatitis delta virus superinfection. J Hepatol 1991; 12(1):64-9.
24. Weltman MD, Brotodihardjo A, Crewe EB, Farrell GC, Bilous M, Grierson JM, et al.: Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment. J Viral Hepat 1995; 2(1):39-45.
25. Erhardt A, Gerlich W, Starke C, Wend U, Donner A, Sagir A, et al.: Treatment of chronic hepatitis delta with pegylated interferon-a2b. Liver Int 2006; 26:805-10. (Pubitemid 44172032)